OverviewSuggest Edit
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. It operates in two business segments: Pfizer Biopharmaceuticals Group (Biopharma) and Upjohn. The Biopharma segment offers medicines, vaccines, and biosimilars for the treatment of cardiovascular and metabolic diseases, oncology diseases, pneumococcal disease, meningococcal disease and tick-borne encephalitis, chronic immune and inflammatory diseases, as well as rare diseases, including amyloidosis, hemophilia, and endocrine diseases. The Upjohn segment provides products that are used to treat non-communicable diseases across a range of therapeutic areas, including cardiovascular, pain and neurology, psychiatry, urology, and ophthalmology.
| Type | Public | |
| Founded | 1849 | |
| HQ | New York, NY, US | Map |
| Website | pfizer.com | |
| Employee Ratings | More | |
| Overall Culture | B | More |
Recent NewsAll News
- Dow skids to session low Friday morning amid report that Pfizer vaccines in EU may face delays
- Thinking about trading options or stock in Axon Enterprise, Tilray, Pfizer, Crispr Therapeutics, or General Motors?
- Pfizer to temporarily reduce vaccine deliveries to UK and EU
- European Pharmaceutical Contract Development and Manufacturing Organization Market Outlook to 2030, Featuring Aenova Group, Baxter BioPharma Solutions, Catalent Inc, Pfizer CentreSource and More.
Key People/Management at Pfizer
Albert Bourla
Frank D'Amelio
Mikael Dolsten
Lidia Fonseca
Angela Hwang
Rady Johnson
Pfizer Office Locations
Pfizer Financials and Metrics
Pfizer Revenue
| USD | |
|---|---|
Revenue (Q3, 2020) | 12.1b |
Gross profit (Q3, 2020) | 9.6b |
Gross profit margin (Q3, 2020), % | 79.2% |
Net income (Q3, 2020) | 2.2b |
Market capitalization (15-Jan-2021) | 204.0b |
Closing stock price (15-Jan-2021) | 36.7 |
Cash (27-Sept-2020) | 1.6b |
EV | 265.6b |
| USD | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | 3.6b | 7.4b | 11.6b | 3.9b | 8.9b | 16.6b | 3.4b | 6.8b | 9.0b |
Depreciation and Amortization | 1.6b | 3.1b | 4.7b | 1.5b | 3.1b | 4.6b | 1.2b | 2.5b | 3.7b |
Cash From Operating Activities | 2.0b | 5.8b | 11.1b | 1.7b | 4.3b | 8.8b | 3.1b | 6.7b | 8.8b |
Purchases of PP&E | (386.0m) | (810.0m) | (1.4b) | (460.0m) | (939.0m) | (1.5b) | (463.0m) | (942.0m) | (1.5b) |
| USD | FY, 2017 |
|---|---|
EV/CFO | 15.7 x |
Revenue/Employee | 582.5k |
Debt/Equity | 0.6 x |
Debt/Assets | 0.3 x |
Financial Leverage | 2.4 x |
P/E Ratio | 10.2 |
Pfizer Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Array BioPharma | June 18, 2019 | $11.40 b |
| Therachon | May 08, 2019 | $340 m |
| Medivation | August 22, 2016 | $14 b |
| Bamboo Therapeutics | August 01, 2016 | $654 m |
| BIND Therapeutics, Inc. | July 27, 2016 | $40 m |
| Anacor Pharmaceuticals | June 24, 2016 | $5.20 b |
| Hospira | February 05, 2015 | $15 b |
| Redvax | January 05, 2015 | |
| Baxter International - Marketed Vaccines | July 30, 2014 | $635 m |
| InnoPharma | July 16, 2014 | $225 m |
Pfizer Revenue Breakdown
Pfizer revenue breakdown by business segment: 19.8% from Upjohn, 76.2% from Biopharma and 4.1% from Other
Pfizer revenue breakdown by geographic segment: 16.8% from Developed Europe, 46.1% from United States, 24.6% from Emerging Markets and 12.5% from Developed Rest of World
Pfizer Cybersecurity Score
Pfizer Environment, Social & Governance (ESG) Ratings
Pfizer Online and Social Media Presence
23.06k Twitter followers
Pfizer has 23.06k Twitter Followers. The number of followers has increased 3.7% month over month and increased 10% quarter over quarter
Pfizer's Trends
Twitter Engagement Stats for @pfizer_news
870
Tweets
866
Following
23.1k
Followers
7
Tweets last 30 days
15.4
Avg. likes per Tweet
100%
Tweets with engagement
Pfizer Company Culture
Overall Culture
B
69/100
CEO Rating
C+
68/100
Compensation
B
72/100
Diversity
B-
68/100
Pfizer News and Updates
Dow skids to session low Friday morning amid report that Pfizer vaccines in EU may face delays
Thinking about trading options or stock in Axon Enterprise, Tilray, Pfizer, Crispr Therapeutics, or General Motors?
Pfizer to temporarily reduce vaccine deliveries to UK and EU
European Pharmaceutical Contract Development and Manufacturing Organization Market Outlook to 2030, Featuring Aenova Group, Baxter BioPharma Solutions, Catalent Inc, Pfizer CentreSource and More.
Japan Seeks Mid-February Pfizer Vaccine Approval, Minister Says
Podcast: The vaccine pipeline, beyond Pfizer and Moderna
Pfizer Blogs
INDEPENDENT MEDICAL EDUCATION
Pfizer Frequently Asked Questions
When was Pfizer founded?
Pfizer was founded in 1849.
Who are Pfizer key executives?
Pfizer's key executives are Albert Bourla, Frank D'Amelio and Mikael Dolsten.
How many employees does Pfizer have?
Pfizer has 88,300 employees.
What is Pfizer revenue?
Latest Pfizer annual revenue is $51.8 b.
What is Pfizer revenue per employee?
Latest Pfizer revenue per employee is $586.1 k.
Who are Pfizer competitors?
Competitors of Pfizer include Bayer, GSK and Eli Lilly.
Where is Pfizer headquarters?
Pfizer headquarters is located at 235 E 42nd St, New York.
Where are Pfizer offices?
Pfizer has offices in New York, Buenos Aires, Villa Adelina, Bentley and in 79 other locations.
How many offices does Pfizer have?
Pfizer has 90 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies